Each year, the Congress of Neurological Surgeons’ (CNS) Annual Meeting offers the latest in neurosurgical innovations from today’s clinical experts—and this year, The Valley Hospital’s own Anthony D’Ambrosio, M.D., will be among the medical leaders sharing his expertise.
Dr. D’Ambrosio—a neurosurgeon and Co-Director of the Gamma Knife Center—has been selected to present his abstract, “Community Cancer Center Experience Using Gamma Knife Perfexion Radiosurgery as Stand-Alone and Adjuvant Treatment for Recursive Partitioning Analysis Class I and II Patients with Brain Metastases.” The abstract will be available as a digital poster during the CNS 2014 Annual Meeting, taking place Oct. 18-22 in Boston, Mass.
In this abstract, Dr. D’Ambrosio and his co-authors looked at the effectiveness and safety of gamma knife radiosurgery in 63 patients with class I and II brain metastases. They found that using gamma knife radiosurgery—either as a first-line treatment or an adjuvant therapy—offers survival rates comparable to combining radiosurgery with whole brain radiation therapy. In addition, more than 70 percent of the patients studied were able to avoid whole brain radiation therapy for as long as 18 months after receiving gamma knife treatment, leading the authors to recommend using gamma knife radiosurgery as a stand-alone therapy.
Founded in 1951, the CNS is a leader in neurosurgical education and advancement, with more than 7,000 members across the globe.
